Mylan Third Quarter 2015 Constant Currency Adjusted Total Revenues Increase 36% and Adjusted Diluted EPS Increases 23% to $1.43

Go back to Mylan Third Quarter 2015 Constant Currency Adjusted Total Revenues Increase 36% and Adjusted Diluted EPS Increases 23% to $1.43

RBC Capital Cuts Price Target on Mylan (MYL) Ahead of PRGO Acquisition Tender deadline

November 2, 2015 9:39 AM EST

RBC Capital maintained a Sector Perform rating on Mylan (NASDAQ: MYL), and cut the price target to $60.00 (from $64.00), as focus is now squarely on the 11/13 tender deadline in MYL's attempt to acquire PRGO. Lingering questions continue to surround the company.

Analyst Randall Stanicky... More

Guggenheim Sidelined on Mylan (MYL) Until More Clarity on M&A Strategy, FY18 Expectations is Offered

October 30, 2015 11:28 AM EDT

Guggenheim remains Neutral on Mylan (Nasdaq: MYL) following Q3 results issued earlier Friday.

Analyst Louise Chen noted the following key points from the report:

Appointment of Ranjan Ray Chaudhuri (strong OTC experience) underscores MYL's commitment to acquiring PRGO, in our view;Strong... More

Mylan (MYL) Tops Q3 EPS by 5c; Sees FY15 EPS at High End of Outlook

October 30, 2015 7:02 AM EDT

Mylan (NASDAQ: MYL) reported Q3 EPS of $1.43, $0.05 better than the analyst estimate of $1.38. Revenue for the quarter came in at $2.71 billion versus the consensus estimate of $2.79 billion.

Mylan CEO Heather Bresch commented, "Our outstanding third quarter results underscore the diversity of Mylan's platform... More